CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$0.80
+0.05 (+6.65%)
Open$0.83
Previous Close$0.75
Day High$0.83
Day Low$0.68
52W High$18.70
52W Low$12.09
Volume—
Avg Volume110.5K
Market Cap10.17M
P/E Ratio—
EPS$0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,049.0% upside
Current
$0.80
$0.80
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.08M | 1.91M | 2.00M |
| Net Income | 160.9K | 134.3K | 123.6K |
| Profit Margin | 7.7% | 7.0% | 6.2% |
| EBITDA | 232.9K | 222.2K | 203.5K |
| Free Cash Flow | 210.3K | 168.1K | 175.1K |
| Rev Growth | +11.7% | +10.4% | -4.6% |
| Debt/Equity | 0.47 | 0.39 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |